The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease. Rationale and design of the FLAX-PAD randomized controlled trial

Contemporary Clinical Trials

Volumn 32, Issue 5, 2011, Pages 724-730

  Leyva, Delfin Rodriguez ^a   Zahradka, Peter ^b   Ramjiawan, Bram ^b   Guzman, Randy ^b   Aliani, Michel ^b   Pierce, Grant N ^a  

^a Cardiovascular Research Division   (Cuba)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alpha linolenic acid; Flaxseed; Natural Health Products; Nutrition; Peripheral arterial disease; Secondary prevention

Indexed keywords

LINOLENIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; DIETARY INTAKE; EXERCISE; FEMALE; HEART INFARCTION; HUMAN; LINSEED; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; STROKE;

AGED; ALPHA-LINOLENIC ACID; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FLAX; HUMANS; MALE; NUTRITIONAL STATUS; PERIPHERAL ARTERIAL DISEASE; PHYTOTHERAPY; PLANT PREPARATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE;

EID: 79960889884     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2011.05.005     Document Type: Article

References (40)

1. de Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J.L., Monjaud I., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994, 143:1454-1459.
2. de Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779-785.
3. Dietary supplementation with n-3 poly unsaturated fatty acids and vitamin E in 11, 324 patients with myocardial infarction. Results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455. GISSI-Prevenzione Investigators.
4. Yamada T., Strong J.P., Ishii T., Ueno T., Koyama M., Wagayama H., et al. Atherosclerosis and omega-3 fatty acids in the populations of a fishing village and a farming village in Japan. Atherosclerosis 2000, 153:469-481.
5. Hu F.B., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001, 20:5-19.
6. Hennig B., Toborek M., McClain C.J. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J Am Coll Nutr 2001, 20:91-105.
7. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study: case-control study. Lancet 2004, 364:937-952.
8. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult treatment panel III). JAMA 2001, 285:2486-2497.
9. Leaf A. Dietary prevention of coronary heart disease: the Lyon Diet Heart Study. Circulation 1999, 99:733-735.
10. Gebauer S.K., Psota T.L., Harris W.S., Kris-Etherton P.M. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006, 83:1526S-1535S.
11. Ander B.P., Weber A.R., Rampersad P., Gilchrist J.S.C., Pierce G.N., Lukas A. Flaxseed protects against ventricular arrhythmias induced by ischemia-reperfusion in normal and hypercholesterolemic rabbits. J Nutr 2004, 134:3250-3256.
12. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol Cell Biochem 1997, 168:117-123.
13. Kitts D.D., Yuan Y.V., Wijewickreme A.N., Thompson L.U. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 1999, 202:91-100.
14. Dupasquier C.M.C., Weber A.M., Ander B.P., et al. The effects of dietary flaxseed on vascular contractile function and atherosclerosis in rabbits during prolonged hypercholesterolemia. Am J Physiol 2006, 291:H2987-H2996.
15. Dupasquier C.M.C., Dibrov E., Kostenuk A.L., Rampersad P.P., Steigerwald S., Wigle J.T., et al. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol 2006, 291:H2987-H2996.
16. Morris D. Essential nutrients and other functional compounds in flaxseed. Nutrition Today 2001, 36:159-162.
17. Prasad K. Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 1997, 132:69-76.
18. Prasad K., Mantha S.V., Muir A.D., Westcott N.D. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 1998, 136:367-375.
19. Cunnane S.C., Hamadeh M.J., Liede A.C., Thompson L.U., Wolever T.M., Jenkins D.J. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 1995, 61:62-68.
20. Cunnane S.C., Ganguli S., Menard C., Liede A.C., Hamadeh M.J., Chen Z.Y., et al. High alpha linolenic acid flaxseed (Linum usitstissimum): some nutritional properties in humans. Br J Nutr 1993, 69:443-453.
21. Ruckley V.C. Claudication. Br Med J (Clin Res Ed) 1986, 292:970-971.
22. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001, 344:1608-1621.
23. Beebe H.G. Intermittent claudication: effective medical management of a common circulatory problem. Am J Cardiol 2001, 87:14D-18D.
24. Goodall S. Risk factor assessment for patients with peripheral arterial disease. Prof Nurse 2001, 17:27-30.
25. Murabito J.M., D'Agostino R.B., Silbershatz H., Wilson W.F. Intermittent claudication. A risk profile from the Framingham Heart Study. Circulation 1997, 96:44-49.
26. Kannel W.B., McGee D.L. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985, 33:13-18.
27. Aronow W.S., Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62years of age. Am J Cardiol 1994, 74:64-65.
28. Hirsch A.T., Treat-Jacobson D., Lando H.A., Hatsukami D.K. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease. Vasc Med 1997, 2:243-251.
29. Austria J.A., Richard M.N., Chahine M.N., Edel A.L., Malcolmson L.J., Dupasquier C.M.C., et al. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr 2008, 27:214-221.
30. van der Harst P., Voors A.A., Volbeda M., Buikema H., van Veldhuisen D.J., van Gilst W.H. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting. Am J Cardiol 2006, 97:1697-1701.
31. van der Harst P., Asselbergs F.W., Buikema H., Voors A.A., van Veldhuisen D.J., van Gilst W.H. Effects of C-reactive protein and cholesterol on responsiveness in vitro of the internal thoracic artery to angiotensin II in patients having coronary artery bypass grafting. Am J Cardiol 2006, 98:751-753.
32. Kawamura T., Kadosaki M., Nara N., Wei J., Endo S., Inada K. Nicorandil attenuates NF- kappaB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery. Shock 2005, 24:103-108.
33. Schmidt-Lucke C., Rössig L., Fichtlscherer S., Vasa M., Britten M., Kämper U., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-2987.
34. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
35. Molina H., Bunkenborg J., Reddy G.H., Muthusamy B., Scheel P.J., Pandey A. A proteomic analysis of human hemodialysis fluid. Mol Cell Proteomics 2005, 4:637-650.
36. Abe E., Matsubara K., Ochi H., Ito M., Oka K., Kameda K. Elevated levels of adhesion molecules derived from leukocytes and endothelial cells in patients with pregnancy-induced hypertension. Hypertens Pregnancy 2003, 22:31-43.
37. Zhao S.P., Li Y.F. Downregulation of PPARgamma expression in peripheral blood monocytes correlated with adhesion molecules in acute coronary syndrome. Clin Chim Acta 2003, 336:19-25.
38. Dodin S., Lemay A., Jacques H., Legare F., Forest J.C., Masse B. The effects of flaxseed dietary supplement in lipid profile, bone mineral density and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005, 90:1390-1397.
39. Patenaude A., Rodriguez-Leyva D., Edel A.L., Dibrov E., Dupasquier C.M.C., Austria J.A., et al. Bioavailability of alpha linolenic acid from flaxseed diets as a function of the age of the subject. Eur J Clin Nutr 2009, 63:1123-1129.
40. Ahmed A.A., Holub B.J.I. Alteration and recovery of bleeding times, platelet aggregation and supplement of cod liver oil. Lipids 1984, 19:617-624.